FDD Analysis Report
Fastest Labs
Fas-Tes Franchise Systems, LLC
Key Metrics At-a-Glance
See FDD
See FDD
See FDD
of gross sales
See FDD
of gross sales
See FDD
366 units
N/A
Not disclosed
About This Franchise
## Executive Summary
Fastest Labs has emerged as the fastest-growing drug, alcohol, and DNA testing franchise, expanding to 229 locations with 250+ prime markets still available. The low investment ($131,000-$200,000), no medical experience requirement, and high-margin business model appeal to business-focused entrepreneurs. Strong franchisee satisfaction (Franchise Culture100 award winner) and multi-unit expansion by existing owners validate the opportunity. However, reported financials show modest unit economics ($105,000 average gross sales, 10-12 year payback), which warrants careful validation against the competitive threat from the newly merged ARCpoint/Any Lab Test Now entity that now dominates the category.
## The Business
Fastest Labs operates retail drug, alcohol, and DNA testing centers serving businesses, individuals, and legal/government entities. The value proposition centers on speed - tests completed in minutes with rapid results versus hours or days at traditional labs or medical clinics.
Services include pre-employment drug screening, random and post-accident testing, paternity/DNA testing, and other specimen collection services. Revenue comes primarily from B2B relationships with employers, staffing agencies, and contractors requiring ongoing testing programs.
The franchise model requires no medical experience or clinical background, with comprehensive training covering sales, operations, and testing procedures. Tests cost $40-$49 for consumers, with B2B contracts generating recurring revenue.
## The Numbers
**Initial Investment:** $131,000 - $200,000
**Franchise Fee:** $59,500
**Royalty:** 7% of gross sales
**Financial Requirements:** - $50,000-$75,000 liquid capital - Strong networking and business development skills
**Item 19 Performance:** - Average Gross Sales: $105,449 - Estimated Earnings: $14,763 - $18,981 - Payback Period: 10.3 - 12.3 years
Note: The payback period suggests modest unit economics that warrant validation. Actual performance may vary significantly based on B2B account acquisition success.
## System Health
Fastest Labs has demonstrated impressive growth since founding in 2008 and franchising in 2010:
**Current Metrics:** - 228 franchised locations + 1 company-owned = 229 total - 237 locations open with 250+ prime markets available - Headquarters: San Antonio, Texas - Entrepreneur Franchise 500: #488 (2025), #1 in category (2022)
**Geographic Footprint:** - Strongest presence in Texas - Secondary hubs in Virginia, Maryland, Florida, North Carolina - Expansion opportunities in Midwest and Western states
Multi-unit expansion by existing franchisees in California, Texas, and Washington validates the model and signals franchisee confidence.
## Franchisee Experience
The franchise has built a strong culture, earning inclusion in the 2021 Franchise Culture100 Awards based on leadership, core values, integrity, and support metrics.
Franchisee testimonials highlight: - Turnkey business model with comprehensive training (3 weeks at HQ) - No medical skills required; all training provided - Rapid implementation of business systems - Strong coaching and ongoing support - Technology adoption and innovation support
Notable franchisee stories: - First franchisee (2011) transitioned from insurance, values independence with corporate support - Veteran franchisee Dave George praised training and technology, expanded from 2 to 4 locations - Early national expansion franchisee cited excellent coaching and franchise support
The Franchise Support Initiative 12 (FSI XII) program rolls out monthly support tools and initiatives.
## Risk Assessment
The FDD reportedly does not disclose lawsuits or bankruptcy information, though prospective franchisees should review full FDD terms.
Key risks include:
**Competitive Consolidation:** - August 2024: ARCpoint Labs and Any Lab Test Now merged into CRESSO Brands, creating the largest franchise direct access lab testing group in the U.S. - Combined entity has 365+ locations versus Fastest Labs 229 - Increased competitive pressure from better-capitalized combined competitor
**Modest Unit Economics:** - $105,000 average gross sales appears low for 10+ year payback - Earnings estimates of $15,000-$19,000 suggest thin margins - Success heavily dependent on B2B account development
**Business Development Dependency:** - Revenue growth requires active sales/networking effort - Not a passive investment; requires ongoing business development - Market saturation risk in mature territories
**Economic Sensitivity:** - Drug testing demand correlates with employment levels - Economic downturns reduce hiring and associated testing volume - B2B client concentration risk if major accounts lost
## Competitive Position
Fastest Labs competes in the $7 billion lab testing industry against:
**Franchise Competitors:** - Any Lab Test Now: 235+ locations, 70.5% ownership of CRESSO Brands - ARCpoint Labs: 130+ locations, 29.5% ownership of CRESSO Brands
**Non-Franchise Competitors:** - Quest Diagnostics: Largest lab chain in U.S. - LabCorp: Major national competitor - Medical clinics and urgent care centers
**Competitive Comparison:**
| Factor | Fastest Labs | Any Lab Test Now | ARCpoint Labs | |--------|-------------|------------------|---------------| | Investment | $131K-$200K | $42K-$238K | $199K-$380K | | Franchise Fee | $59,500 | $40,000 | $54,500 | | Royalty | 7% | 8% | 7% | | Units | 229 | 235+ | 130+ |
Fastest Labs differentiates on speed - tests completed in minutes versus 45+ minutes at competitors. This speed advantage appeals to time-sensitive business clients.
## Validation Questions
1. What is your actual gross revenue and net profit compared to the system averages? 2. How long did it take to build a sustainable B2B client base? 3. What percentage of your revenue comes from recurring B2B contracts versus walk-in consumers? 4. How has the ARCpoint/Any Lab Test Now merger affected competition in your market? 5. What are your actual operating costs, and how do they compare to the FDD estimates? 6. How effective is corporate support in business development and marketing? 7. What is your client retention rate for B2B accounts?
## Data Gaps
- Reconciliation of reported modest financials versus strong franchisee expansion patterns - Impact of CRESSO Brands merger on competitive dynamics - Client acquisition costs and sales cycle length - Geographic performance variation by market type - Revenue breakdown between B2B and consumer segments - Actual profit margins versus estimated earnings range
Ongoing Fees
| Fee Type | Amount | Notes |
|---|---|---|
| Royalty | See FDD of Gross Revenue | - |
| Brand Fund | See FDD of Gross Revenue | - |
Item 19: Financial Performance Representations
No Financial Performance Representations
This franchisor does not provide Item 19 financial performance representations. Approximately 35% of franchisors choose to disclose this information.
Recommendation: Request financial information directly from existing franchisees listed in Exhibit I during your due diligence. Contact 10-15 franchisees to gather revenue and profitability data before making an investment decision.
Learn more about Item 19 disclosures →Risk Assessment
Items to Review
No notable items identified
Positive Indicators
Review FDD for positive factors
Due Diligence Recommendations
Contact 10-15 existing franchisees to gather operational and financial insights
Franchisee interviews are the most valuable source of information about day-to-day operations and realistic financial expectations.
Have a franchise attorney review the Franchise Agreement
Professional legal review can identify unfavorable terms and potential negotiation points.
Research local market conditions and competition
Understanding your specific market is essential for success, regardless of system-wide performance.
Download Complete FDD
Access the full Franchise Disclosure Document including all 23 items, exhibits, and financial statements.
Browse Similar Franchises
Learn More About FDDs
New to franchise investing? Our educational guides will help you understand what to look for in the Fastest Labs FDD.
The Ultimate Guide to FDDs
Learn how to read and analyze Franchise Disclosure Documents
Understanding Item 7: Initial Investment
How to evaluate franchise investment costs
FDD Item 5: Initial Fees Explained
What you pay upfront to become a franchisee
Item 20: Franchisee Information
Analyze system growth and contact franchisees
About Fastest Labs Franchise
Fastest Labs is a franchise that offers entrepreneurs the opportunity to own and operate their own business within an established system. As of the 2026 Franchise Disclosure Document, the system has grown to 366 locations across the United States. This analysis provides prospective franchisees with key insights from the FDD to support informed investment decisions.
Fastest Labs Franchise Cost
The total initial investment required to open a Fastest Labs franchise ranges from See FDD for details. This investment includes the initial franchise fee of See FDD for details, along with expenses for real estate, equipment, inventory, training, and working capital to sustain operations during the initial period. Ongoing fees include a royalty fee of See FDD of gross sales. Prospective franchisees should review Item 7 of the FDD for a complete breakdown of estimated initial investment costs.
Fastest Labs Item 19 Financial Performance
Fastest Labs does not provide financial performance representations in Item 19 of their FDD. Approximately 35% of franchisors choose to disclose this information. Without franchisor-provided financial data, prospective franchisees should contact existing franchisees directly to gather information about revenue, expenses, and profitability. The franchisee contact list in Exhibit I provides names and contact information for current and former franchise owners.
Fastest Labs Franchise Growth and System Health
The Fastest Labs franchise system has shown stable performance based on unit count data from Item 20 of the FDD. Prospective franchisees should examine the historical data on unit openings, closings, and transfers to understand the system's trajectory and identify any concerning trends.
Fastest Labs Franchise Investment Considerations
The Fastest Labs FDD contains important disclosures that prospective franchisees should carefully review before making an investment decision. Key factors to evaluate include the franchise fee structure, ongoing royalty requirements, territory rights, termination history, and franchisor support systems. Every franchise investment carries risk, and this analysis should be combined with professional legal and financial advice. Review the complete FDD and speak with current franchisees to gain a comprehensive understanding of the opportunity.
Due Diligence Recommendations for Fastest Labs
Before investing in a Fastest Labs franchise, prospective franchisees should:
- Contact multiple existing franchisees to gather operational and financial insights
- Have a franchise attorney review the Franchise Agreement and all exhibits
- Research local market conditions and competitive landscape
- Develop a detailed business plan with realistic financial projections
- Verify all information provided by the franchisor independently
Download the Fastest Labs FDD
Access the complete Fastest Labs Franchise Disclosure Document, including all 23 Items, exhibits, franchise agreement, and audited financial statements. FreeFDDs™ provides free access to FDDs to promote franchise transparency and help prospective franchisees make informed decisions. The FDD contains critical information that should be reviewed in its entirety before making any investment decision.
Disclaimer
This analysis report is provided for informational purposes only. The data presented has been extracted from the Franchise Disclosure Document and may contain errors or omissions.
Prospective franchisees should conduct their own due diligence, review the complete FDD document, and consult with qualified legal and financial advisors before making any investment decisions.